Baum M. Effect of catecholamines on rat medullary thick ascending limb chloride transport: interaction with angiotensin II. Am J Physiol Regul Integr Comp Physiol 298: R954 -R958, 2010. First published February 10, 2010 doi:10.1152 doi:10. /ajpregu.00758.2009vious studies have shown that in proximal and distal tubule nephron segments, peritubular ANG II stimulates sodium chloride transport. However, ANG II inhibits chloride transport in the medullary thick ascending limb (mTAL). Because ANG II and catecholamines are both stimulated by a decrease in extracellular fluid volume, the purpose of this study was to examine whether there was an interaction between ANG II and catecholamines to mitigate the inhibition in chloride transport by ANG II. In isolated perfused rat mTAL, 10 Ϫ8 M bath ANG II inhibited transport (from a basal transport rate of 165.6 Ϯ 58.8 to 58.8 Ϯ 29.4 pmol · mm Ϫ1 · min Ϫ1 ; P Ͻ 0.01). Bath norepinephrine stimulated chloride transport (from a basal transport rate of 298.1 Ϯ 31.7 to 425.2 Ϯ 45.8 pmol · mm Ϫ1 · min Ϫ1 ; P Ͻ 0.05) and completely prevented the inhibition in chloride transport by ANG II. The stimulation of chloride transport by norepinephrine was mediated entirely by its ␤-adrenergic effect; however, both the ␤-and ␣-adrenergic agonists isoproterenol and phenylephrine prevent the ANG II-mediated inhibition in chloride transport. In the presence of 10 Ϫ5 M propranolol, the effect of norepinephrine to prevent the inhibition of chloride transport by ANG II was still present. These data are consistent with an interaction of both ␣-and ␤-catecholamines and ANG II on net chloride transport in the mTAL. NKCC2; norepinephrine; isoproterenol ANGIOTENSIN II IS ONE OF THE factors responsible for increasing sodium absorption in the face of volume depletion. In addition to hemodynamic effects, ANG II has been shown to have a direct epithelial action to regulate sodium absorption along the nephron. Using in vivo micropuncture and in vitro microperfusion, ANG II has been shown to increase sodium chloride and volume absorption in the proximal tubule (3, 8, 20, 26 -28, 42, 45). Likewise, sodium transport has been shown to be stimulated in the macula densa by ANG II (5, 24, 36) . In an in vivo microperfusion study, ANG II was found to stimulate acidification and sodium absorption in the distal convoluted tubule (44). ANG II increased transcellular chloride transport and sodium transport across the epithelial sodium channel in the cortical collecting tubule (35, 37) . Despite the increase in sodium absorption in almost every nephron segment, ANG II was found to decrease chloride transport in the medullary thick ascending limb (mTAL), a nephron segment responsible for a substantive amount of sodium chloride absorption (25).
NKCC2; norepinephrine; isoproterenol ANGIOTENSIN II IS ONE OF THE factors responsible for increasing sodium absorption in the face of volume depletion. In addition to hemodynamic effects, ANG II has been shown to have a direct epithelial action to regulate sodium absorption along the nephron. Using in vivo micropuncture and in vitro microperfusion, ANG II has been shown to increase sodium chloride and volume absorption in the proximal tubule (3, 8, 20, 26 -28, 42, 45) . Likewise, sodium transport has been shown to be stimulated in the macula densa by ANG II (5, 24, 36) . In an in vivo microperfusion study, ANG II was found to stimulate acidification and sodium absorption in the distal convoluted tubule (44) . ANG II increased transcellular chloride transport and sodium transport across the epithelial sodium channel in the cortical collecting tubule (35, 37) . Despite the increase in sodium absorption in almost every nephron segment, ANG II was found to decrease chloride transport in the medullary thick ascending limb (mTAL), a nephron segment responsible for a substantive amount of sodium chloride absorption (25) .
Both the renin-angiotensin system and the renal nerves are stimulated by similar factors that result in a decrease in effective arteriolar pressure. The interdependence of the reninangiotensin system and renal nerves can affect renal salt transport, as well as renal hemodynamics in not only a concordant but in a mutually dependent fashion (10, 11) . As an example of this interdependence, circulating ANG II facilitated adrenergic transmission at the renal nerve-renal epithelial cell junction (18, 21, 22) , so that renal nerve stimulation increased sodium transport in the presence of physiological circulating ANG II and was blunted by administration of captopril (21) . We have previously shown that the stimulation in proximal tubule sodium absorption by the intrarenal renal angiotensin system was regulated by and dependent upon renal nerves (40, 41) .
Previous studies have shown that ␤-catecholamines stimulate sodium chloride transport in the mTAL (1, 29, 38) . Since proximal and distal nephron segments have an increase in sodium transport with ANG II, the present study reexamined whether ANG II decreases mTAL transport. In addition, this study examined whether there was an interaction of the effect of ANG II and catecholamines on sodium chloride transport in this segment.
METHODS

Animals.
Adult male and female Sprague-Dawley rats weighing between 90 and 210 g were used in these studies. Rats were given intraperitoneal furosemide (2 mg/100 g body wt) ϳ5 min prior to receiving intraperitoneal Inactin (10 mg/100 g body wt). After the rats were under anesthesia, the abdomen was opened to expose the left kidney, which was bathed for 1 min in ice-cold PBS. The kidney was then removed and cut into several coronal slices for microdissection (15, 17, 23) . These studies were approved by the Institutional Animal Care and Use Committee at the University of Texas Southwestern Medical Center.
In vitro microperfusion flux studies. Segments of rat mTAL were dissected free hand and perfused with an ultrafiltrate-like solution that contained (in mM) 115 NaCl, 25 NaHCO 3, 4.0 Na2HPO4, 10 Na acetate, 1.8 mM CaCl 2, 1 MgSO4, 5 KCl, 8.3 glucose, 5 alanine, 2 lactate, and 2 glutamine at 4 or 5 nl/min. The tubules were bathed in a similar solution containing 6 g/dl of BSA. The osmolality of all solutions was adjusted to 300 mosmol/kg H 2O. The bathing solution was heated to 38°C and exchanged at 0.5 ml/min to maintain a constant pH and osmolality.
The rate of chloride transport in the medullary thick ascending limbs (mTAL) was calculated as J Cl ϭ (Vl) (Clo Ϫ Cll)Po/CloL where V 1 is the collection rate, Clo and Cll were the chloride concentrations in the perfusion solution and the collected fluid, respectively, in counts per minute per nanoliter. P o is the perfusate chloride concentration in millimoles and L is the tubular length in mm. The tubule lengths were measured with an eyepiece micrometer. The mean tubular length was 0.5 Ϯ 0.1 mm. The perfusion solution contained 36 Cl at a concentration of 10 Ci/ml. A 30-nl constant-volume pipette was used to measure the collection rate. Tubules were perfused at ϳ5 nl/min. Tubules were incubated for ϳ15 min before initiation of the measurements for chloride absorption and between periods. There were at least three measurements per period, and the mean of the collections in each period was used to represent the chloride absorp-tion. We have previously demonstrated that there is no detectable passive chloride transport in this segment and thus no chloride backflux (9) .
The transepithelial potential difference was measured using the perfusion pipette that was inserted into the tubular lumen. The reference electrode was in the bathing solution. The potential difference was measured using a Keithley Electrometer, model no. 6517B (Keithley, Cleveland, OH).
Statistics. There was variability in the basal transport rate in mTAL with older rats having the highest rate of chloride transport; however, all studies were conducted in a paired fashion, and the results were consistent independent of the basal rate of transport. Paired Student's t-test was used to measure the difference in experimental periods when two periods were compared. Analysis of variance was used to determine statistical significance for studies with more than two groups. Data are expressed as means Ϯ SE.
RESULTS
In the first series of experiments, rat mTAL was perfused in vitro, and chloride transport was measured. We have previously shown that under these conditions, the chloride transport measured was entirely due to active transport (9) . I first examined whether 2ϫ10 Ϫ11 M ANG II affected chloride transport in the mTAL. The rate of chloride transport was 148.9 Ϯ 17.7 in the control period and 129.2 Ϯ 14.5 pmol·mm Ϫ1 ·min
Ϫ1
after the addition of ANG II, confirming that the plasma concentration of ANG II in a euvolemic animal does not affect mTAL transport (25) . Similarly, 10 Ϫ10 M ANG II had no effect on chloride transport (271. (25) . Similarly, 10 Ϫ8 M ANG II caused a reduction in the transepithelial potential difference from positive 4.6 Ϯ 0.7 to 3.7 Ϯ 0.7 mV, P Ͻ 0.01.
I next examined whether 10 Ϫ6 M bath norepinephrine affected transport or influenced the effect of bath ANG II. These results are shown in Fig. 2 . Bath norepinephrine caused a significant increase in chloride transport. This confirmed previous studies showing that this concentration of norepinephrine increases chloride transport in this nephron segment (38) In addition, when 10 Ϫ8 M ANG II was added to the bathing solution in the third period in the presence of norepinephrine, the ANG II-mediated decrease in chloride transport was prevented. Norepinephrine caused an increase in the transepithelial potential difference from 9.0 Ϯ 0.5 to 13.8 Ϯ 1.1 mV, P Ͻ 0.001 and prevented the decrease in potential difference by ANG II (13.0 Ϯ 0.9 mV P ϭ not significant, ns) I also examined whether 2 ϫ 10 Ϫ11 ANG II affected chloride transport in the presence of bath 10 Ϫ6 M norepinephrine. Chloride transport was 325.8 Ϯ 37.4 pmol·mm Ϫ1 ·min Ϫ1 in the presence of 10 Ϫ6 M norepinephrine and 294.5 Ϯ 36.6 pmol·mm Ϫ1 ·min Ϫ1 when 2 ϫ 10 Ϫ11 M ANG II was added to the bathing solution in the presence of norepinephrine (P ϭ ns). Thus, norepinephrine stimulates chloride transport and prevents the decrease in transport by 10 Ϫ8 M ANG II. The next experiments were designed to determine whether the stimulatory effect of norepinephrine on mTAL chloride transport and its effect to prevent the ANG II-mediated decrease in chloride transport was via an ␣-or ␤-effect of catecholamines. The effect of isoproterenol, a ␤-agonist, on chloride transport was next examined as shown in Fig. 3 . Isoproterenol (10 Ϫ6 M) stimulated chloride transport in the mTAL. These results are shown in Fig. 4 . Furthermore, isoproterenol prevented the inhibition in chloride transport mediated by 10 Ϫ8 M ANG II. Isoproterenol also increased the potential difference from 3.7 Ϯ 1.0 to 5.7 Ϯ 1.3 mV, P Ͻ 0.05 and prevented the decrease mediated by ANG II (5.4 Ϯ 1.1 mV, P ϭ ns).
In the next series of experiments shown in Fig. 4 , the effect of the ␣-agonist phenylephrine was examined. The addition of 10 Ϫ6 M phenylephrine to the bathing solution resulted in no change in chloride transport compared with the control period in mTAL. However, phenylephrine also prevented the inhibition of chloride transport mediated by 10 Ϫ8 M ANG II. Thus, Fig. 1 . Effect of ANG II on mTAL chloride transport in the medullary thick ascending limb (mTAL). mTAL was dissected and perfused in vitro. After the control period, 10 Ϫ8 M ANG II was added to the bathing solution. There was a significant decrease in chloride transport with bath ANG II (*P Ͻ 0.01). Ϫ6 M norepinephrine (Norepi) was added to the bathing solution. Norepinephrine caused a significant increase in chloride transport: *P Ͻ 0.05. 10 Ϫ8 M ANG II was then added in the presence of norepinephrine, and the inhibition of chloride transport seen in Fig. 1 was abrogated. while the stimulation in chloride transport in the mTAL is mediated by a ␤-effect of catecholamines in this segment, both ␣-and ␤-effects of catecholamines prevent the inhibition by ANG II. Phenylephrine had no effect on the potential difference compared with control but prevented the decrease in potential difference by ANG II (3.7 Ϯ 1.1 mV control vs. 4.3 Ϯ 1.5 mV phenylephrine vs. 3.9 Ϯ 0.8 mV phenylephrine plus ANG II, P ϭ ns).
In the last series of experiments shown in Fig. 5, I show that 10 Ϫ5 M propranolol blocked the increase in chloride transport by 10 Ϫ6 M norepinephrine. Norepinephrine still prevented the inhibition of chloride transport by 10 Ϫ8 M ANG II in the presence of propranolol. This is consistent with norepinephrine increasing chloride transport via a ␤-adrenergic effect and preventing the decrease in chloride transport by a non-␤ or -␣ effect. Similarly, norepinephrine did not significantly increase the potential difference in the presence of propranolol (3.6 Ϯ 1.3 mV bath propranolol vs. 4.8 Ϯ 2.7 mV bath propranolol plus norepinephrine, P ϭ ns), but it prevented the inhibition of the potential difference by ANG II (5.0 Ϯ 2.5 mV).
DISCUSSION
The present study confirms that ANG II by itself inhibits mTAL chloride transport. However, both ␣-and ␤-catecholamines prevent the inhibition of chloride transport by ANG II. Finally, norepinephrine stimulates chloride transport in the mTAL, an effect due entirely to its ␤-catecholamine effect.
While studies in the proximal tubule and distal convoluted tubule and collecting duct have all shown that ANG II stimulates sodium chloride transport consistent with its known regulatory role to limit sodium losses in the face of volume depletion (3, 5, 8, 20, 24 -28, 35-37, 42, 45) , the effect of ANG II on transport in the mTAL has not been clear. ANG II at 10 Ϫ8 M has been shown previously to inhibit both chloride and bicarbonate transport in the mTAL perfused in vitro when added to the bathing solution (16, 25) . Studies have also examined the effect of ANG II on loop of Henle sodium absorption in vivo, where ANG II resulted in an increase in proximal tubule reabsorption but had no effect on loop of Henle sodium absorption (12) . However, when renal perfusion pressure was normalized to control values during ANG II infusion, there was an increase in proximal and loop of Henle reabsorption with ANG II infusion (12) . While it is possible that sodium absorption in the proximal straight tubule was stimulated to such an extent that net sodium absorption in the Fig. 3 . Effect of isoproterenol and isoproterenol with ANG II on chloride transport in the mTAL. Isoproterenol (Iso) (10 Ϫ6 M) increased chloride transport in mTAL. The addition of 10 Ϫ8 M ANG II had no effect on chloride transport when isoproterenol was in the bathing solution. *P Ͻ 0.05 control vs. isoproterenol. Fig. 4 . Effect of phenylephrine and phenylephrine with ANG II on chloride transport in the mTAL. After the control period 10 Ϫ6 M phenylephrine (PE) was added to the bathing solution. There was no effect of the pure ␣-agonist on chloride transport, but PE prevented the decrease in chloride transport with the addition of 10 Ϫ8 M ANG II to the bathing solution. Ϫ5 M propranolol in the mTAL. To determine whether norepinephrine was acting via an ␣-or ␤-agonist to increase chloride transport, 10 Ϫ5 M propranolol, a ␤-blocker was studied. Propranolol prevented the increase in chloride transport by 10 Ϫ6 M norepinephrine. In the presence of propranolol and norepinephrine, the inhibitory effect of 10 Ϫ8 M ANG II was blocked.
entire loop was either not affected or stimulated in spite of an inhibition in mTAL transport, the magnitude of the inhibition in mTAL chloride transport seen in these in vitro microperfusion studies in the absence of catecholamines makes an inhibition in chloride transport in the mTAL in vivo unlikely. It should be noted that in vivo micropuncture studies were performed in innervated kidneys, which could account for the discrepancy between in vivo and in vitro effects of ANG II. Furthermore, there may be other factors besides renal nerves that are present in vivo that may affect the action of ANG II on the thick ascending limb. The present study showed that norepinephrine prevents the decrease in chloride transport seen with ANG II in the mTAL. There are several other studies that have shown an interaction between hormones that can affect net transport. For example, there is no effect of atrial natriuretic peptide on sodium transport in the proximal tubule (4, 7) . However, in the presence of either ANG II or norepinephrine, atrial natriuretic peptide inhibits proximal tubule transport (13, 14, 19) . The intrarenal renin-angiotensin system regulates proximal tubule transport (39) , an effect abrogated by renal denervation (40) . Likewise, dopamine has no effect on proximal convoluted tubule transport but blunts the stimulation in proximal tubule sodium absorption caused by norepinephrine (2) .
In this study and in previous studies by other investigators, plasma levels of ANG II had no effect on chloride transport in the mTAL (25) . However, this is unlikely the concentration of ANG II in the medulla, as the kidney can generate ANG II independent of the systemic production (6, 31, 43) . Interstitial ANG II levels are ϳ3 nmol/l (32, 33) and can be augmented by chronic infusion of ANG II to twice this concentration (34) . Furthermore, ANG II levels in the medulla are 3-to 4-fold greater than that in the cortex (30) . Thus, the concentration of ANG II used in these and other studies is likely the physiologically relevant concentration (16, 25) .
The present study shows that both norepinephrine and isoproterenol stimulate chloride transport in the mTAL, while the ␣-agonist phenylephrine had no effect. The stimulatory effect of norepinephrine was blocked by propranolol consistent with a ␤-adrenergic effect of norepinephrine to stimulate chloride transport. Previous studies have demonstrated that isoproterenol, at a concentration used in this study, stimulates transport in mouse and rat mTAL (1, 29, 38) . Phenylephrine was also previously found to not affect chloride transport (38) . The present studies extend these previous findings to demonstrate that both ␣-and ␤-agonists block the inhibition of ANG II in the mTAL. The fact that only ␤-agonist stimulates transport in this segment indicates that ␣-and ␤-catecholamines act via different signal transduction pathways. Thus, it is surprising that both the ␣-agonist phenylephrine and the ␤-agonist isoproterenol prevent the effect of ANG II to decrease chloride transport. The fact that propranolol inhibits chloride transport by norepinephrine yet blocks the effect of ANG II is also consistent with an ␣ effect of norepinephrine to block the inhibition of chloride transport by ANG II. Both ␣-and ␤-adrenergic signaling pathways must act to disrupt ANG II signaling at some point in their intracellular signaling. These studies show that hormonal interactions are important in the net regulation of transport in this nephron segment.
Perspectives and Significance
The present study shows that there is an interaction between norepinephrine and ANG II in their actions on chloride transport in the mTAL. This is another example of how different hormones and physiological conditions interact to affect transport. While there are advantages to studying the regulation of transport in vivo, some segments are not accessible, and examination of one factor in isolation of other hormones and renal nerves is often quite difficult. Whole animal clearance studies examine multiple nephron segments at one time and often do not provide mechanistic answers at the cellular level. Direct evaluation of an epithelium using in vitro approaches allows one to study the effect of a single perturbation on transport or signal transduction in a homogeneous cellular preparation. However, there are often interactions in vivo that are not directly obvious in vitro. Thus, it is not better to examine an issue using one approach or another but in vitro studies and in vivo studies should be complementary to examine mechanisms and significance of physiological perturbations.
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